Randomized, double-blind, placebo-controlled study of arginine supplementation in chronic renal failure
- 1 August 1999
- journal article
- clinical trial
- Published by Elsevier BV in Kidney International
- Vol. 56 (2), 674-684
- https://doi.org/10.1046/j.1523-1755.1999.00582.x
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Renal and systemic nitric oxide synthesis in rats with renal mass reductionKidney International, 1997
- Dietary supplementation with L-arginine limits cell proliferation in the remnant glomerulusKidney International, 1995
- Glomerular actions of nitric oxideKidney International, 1995
- Oral administration of L-arginine and captopril in rats prevents chronic renal failure by nitric oxide productionKidney International, 1995
- Arginine feeding modifies cyclosporine nephrotoxicity in rats.JCI Insight, 1993
- Effect of increased availability of endothelium-derived nitric oxide precursor on endothelium-dependent vascular relaxation in normal subjects and in patients with essential hypertension.Circulation, 1993
- L-arginine improves endothelium-dependent vasodilation in hypercholesterolemic humans.JCI Insight, 1992
- l‐ARGININE INFUSION INDUCES HYPOTENSION AND DIURESIS/NATRIURESIS WITH CONCOMITANT INCREASED URINARY EXCRETION OF NITRITE/NITRATE AND CYCLIC GMP IN HUMANSClinical and Experimental Pharmacology and Physiology, 1992
- Dietary Supplementation With l-Arginine Ameliorates the Progression of Renal Disease in Rats With Subtotal NephrectomyAmerican Journal of Kidney Diseases, 1992
- Nitric oxide and angiotensin II. Glomerular and tubular interaction in the rat.JCI Insight, 1992